Skip to Main Content

You’re reading the web edition of STAT Health Tech, our guide to how tech is transforming the life sciences. Sign up to get this newsletter delivered in your inbox every Tuesday and Thursday. 

Notes from a key player in digital health investing


Julie Yoo’s tenure at Andreessen Horowitz has coincided with a sharp rise in the venture capital firm’s investments in digital health and life sciences, including 27 transactions in 2021. She’s driven several prominent deals in tech infrastructure and efforts to transform primary care, where she has a keen sense for factors that will separate the winners from the also-rans. “If you’re truly doing primary care well, you should be willing to absolutely go at risk and take full accountability for all of the patient’s costs of care,” Yoo told Mario. Read their full conversation on a16z’s strategy, how Yoo advises startups to work with incumbents, and more.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Create a display name to comment

This name will appear with your comment

There was an error saving your display name. Please check and try again.